EspositoK, CiotolaM, CarleoD, SchisanoB, SaccomannoF, SassoFC, CozzolinoD, AssaloniR, MeranteD, CerielloA, GiuglianoD. Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome. Diabetes Care, 2006; 29:1071–1076.
2.
HamburgNM, LarsonMG, VitaJA, VasanRS, KeyesMJ, WidlanskyME, FoxCS, MitchellGF, LevyD, MeigsJB, BenjaminEJ. Metabolic syndrome, insulin resistance, and brachial artery vasodilator function in Framingham Offspring participants without clinical evidence of cardiovascular disease. Am J Cardiol, 2008; 101:82–88.
3.
LteifAA, HanK, MatherKJ. Obesity, insulin resistance, and the metabolic syndrome: Determinants of endothelial dysfunction in whites and blacks. Circulation, 2005; 112:32–38.
4.
LindL. Arterial compliance and endothelium-dependent vasodilation are independently related to coronary risk in the elderly: The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Clin Physiol Funct Imaging, 2008; 28:373–377.
5.
SuzukiT, HirataK, ElkindMS, JinZ, RundekT, MiyakeY, Boden-AlbalaB, Di TullioMR, SaccoR, HommaS. Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: The Northern Manhattan Study (NOMAS)Am Heart J, 2008; 156:405–410.
6.
HirschiKK, IngramDA, YoderMC. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol, 2008; 28:1584–1595.
KeymelS, KalkaC, RassafT, YeghiazariansY, KelmM, HeissC. Impairedendothelial progenitor cell function predicts age-dependent carotid intimal thickening. Basic Res Cardiol, 2008; 103:582–586.
14.
VasaM, FichtlschererS, AicherA, AdlerK, UrbichC, MartinH, ZeiherAM, DimmelerS. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res, 2001; 89:E1–E7.
15.
WesterweelPE, VisserenFL, HajerGR, OlijhoekJK, HoeferIE, de BreeP, RafiiS, DoevendansPA, VerhaarMC. Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy. Eur Heart J, 2008; 29:2808–2817.
16.
JialalI, DevarajS, SinghU, HuetBA. Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: Implications for increased cardiovascular risk. Atherosclerosis, 2010[Epub ahead of print]
17.
FadiniGP, MiorinM, FaccoM, BonamicoS, BaessoI, GregoF, MenegoloM, de KreutzenbergSV, TiengoA, AgostiniC, AvogaroA. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol, 2005; 45:1449–1457.
